Hybrid HEOR Associate Director — Payer & Outcomes Strategy

BioMarin Pharmaceutical Inc.

Greater London

Hybrid

GBP 90,000 - 120,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

BioMarin Pharmaceutical Inc. in London is seeking an Associate Director, Health Economics and Outcomes Research to lead payer evidence strategies across early-stage assets.

You will shape patient-relevant outcomes plans and coordinate with Value & Access, Commercial, Medical Affairs and Clinical Development teams. This hybrid role requires deep HEOR expertise, strong collaboration skills and experience with PRO measures, HTA submissions and global value dossiers to support market access across

Qualifications

  • 7+ years of Pharma Industry experience with 4+ years in HEOR roles and 2+ years in patient-relevant outcomes research.
  • Advanced degree in health economics or related field.
  • Strong understanding of market access, value and global HTA frameworks.
  • Experience developing and executing patient-relevant outcomes strategies for payer/HTA.
  • Experience contributing to PRO measure evaluation and validation.
  • Experience supporting HTA submissions and value dossiers.
  • Ability to collaborate across Value & Access, Commercial, Medical Affairs, Clinical Development & Regulatory.
  • Ability to manage multiple initiatives in a fast-paced environment.
  • Developing expertise in patient-reported outcomes with a growing professional network.
  • Experience engaging with HTA agencies, payers, health economists, clinicians, and patient groups.
  • Rare disease experience preferred.

Responsibilities

  • Lead the development, execution and communication of payer evidence strategies aligned with brand and Value & Access priorities for early-stage pipeline assets
  • Collaborate with Value & Access, Commercial, Medical Affairs, Clinical Development & Regulatory Affairs & Patient Advocacy organizations
  • Contribute to payer/HTA requirements related to patient-relevant outcomes and health utility measurement
  • Support assessment of patient-relevant outcomes requirements for HTA and access
  • Ensure payer evidence requirements are incorporated into clinical development plans
  • Lead cross-functional asset-specific patient-relevant outcomes strategies
  • Support patient-relevant endpoint planning and trial implementation
  • Lead early Joint Clinical Assessment strategy development across markets
  • Assess payer evidence gaps and inform integrated evidence planning
  • Manage external partners in PRO development/validation and health state valuation studies
  • Support HTA and regulatory interactions with briefing materials and evidence packages
  • Support engagement with external stakeholders including HTA agencies and patient organizations
  • Lead exploration and interpretation of PRO data to strengthen HTA/value propositions
  • Shape scientific communication plans and dissemination in journals
  • Support BD opportunities assessment against payer/HTA requirements

Skills

HEOR
PRO development
Payer evidence
Cross-functional collaboration
Market access knowledge

Education

Advanced degree in health economics/outcomes research or related
PhD/Master's in health economics, outcomes research, epidemiology, public health, health services research, pharmacy

Job description

BioMarin Pharmaceutical Inc. in London is seeking an Associate Director, Health Economics and Outcomes Research to lead payer evidence strategies across early-stage assets.

You will shape patient-relevant outcomes plans and coordinate with Value & Access, Commercial, Medical Affairs and Clinical Development teams. This hybrid role requires deep HEOR expertise, strong collaboration skills and experience with PRO measures, HTA submissions and global value dossiers to support market access across

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Director, HEOR – Payer & Outcomes Strategy
Senior Director, HEOR – Payer & Outcomes Strategy

BioMarin Pharmaceutical Inc. • Greater London

Hybrid
GBP 140,000 - 200,000
HEOR Associate Director: Payer Evidence & Access Lead
HEOR Associate Director: Payer Evidence & Access Lead

Biomarin • Greater London

Hybrid
GBP 90,000 - 130,000
Associate Director, Health Economics & Outcomes Research (Heor)
Associate Director, Health Economics & Outcomes Research (Heor)

Biomarin • England

On-site
GBP 90,000 - 130,000
Associate Director, Health Economics & Outcomes Research (HEOR)
Associate Director, Health Economics & Outcomes Research (HEOR)

BioMarin Pharmaceutical Inc. • Greater London

On-site
GBP 90,000 - 120,000
Global HEOR Strategy Lead — Payer & HTA (Hybrid)
Global HEOR Strategy Lead — Payer & HTA (Hybrid)

UCB S.A. • Reading

Hybrid
GBP 90,000 - 140,000
Hybrid work model (40% office)
Senior Director, Health Economics & Outcomes Research (HEOR)
Senior Director, Health Economics & Outcomes Research (HEOR)

BioMarin Pharmaceutical Inc. • Greater London

On-site
GBP 140,000 - 200,000
Global HEOR Strategy Lead: Payer Evidence & Access
Global HEOR Strategy Lead: Payer Evidence & Access

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Medical Science Director, Evidence & Trials (Hybrid, London)
Medical Science Director, Evidence & Trials (Hybrid, London)

Biomarin • Greater London

Hybrid
GBP 120,000 - 180,000
Global HEOR Strategy Lead, Payer & Value Insights
Global HEOR Strategy Lead, Payer & Value Insights

UCB S.A. • Slough

Hybrid
GBP 90,000 - 130,000
Hybrid work model
Global exposure
Medical Scientific Director, Observational Studies Leader
Medical Scientific Director, Observational Studies Leader

BioMarin Pharmaceutical Inc. • Greater London

Hybrid
GBP 110,000 - 165,000